Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $774,379 - $950,031
-9,017 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$48.02 - $79.04 $14,454 - $23,791
-301 Reduced 3.23%
9,017 $661,000
Q2 2019

Aug 14, 2019

BUY
$39.26 - $54.21 $350,984 - $484,637
8,940 Added 2365.08%
9,318 $505,000
Q1 2019

May 10, 2019

SELL
$29.84 - $43.92 $266,769 - $392,644
-8,940 Reduced 95.94%
378 $9.32 Million
Q3 2017

Nov 28, 2017

BUY
$33.75 - $41.67 $314,482 - $388,281
9,318 New
9,318 $372,000
Q3 2017

Nov 14, 2017

SELL
$33.75 - $41.67 $314,482 - $388,281
-9,318 Closed
0 $0
Q3 2016

Dec 04, 2017

BUY
N/A
9,318
9,318 $251,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.